Literature DB >> 18213578

Influence of hormones and hormone metabolites on the growth of Schwann cells derived from embryonic stem cells and on tumor cell lines expressing variable levels of neurofibromin.

Therese M Roth1, Poornapriya Ramamurthy, David Muir, Margaret R Wallace, Yuan Zhu, Lou Chang, Kate F Barald.   

Abstract

Loss of neurofibromin, the protein product of the tumor suppressor gene neurofibromatosis type 1 (NF1), is associated with neurofibromas, composed largely of Schwann cells. The number and size of neurofibromas in NF1 patients have been shown to increase during pregnancy. A mouse embryonic stem cell (mESC) model was used, in which mESCs with varying levels of neurofibromin were differentiated into Schwann-like cells. NF1 cell lines derived from a malignant and a benign human tumor were used to study proliferation in response to hormones. Estrogen and androgen receptors were not expressed or expressed at very low levels in the NF1+/+ cells, at low levels in NF1+/-cells, and robust levels in NF1-/-cells. A 17beta-estradiol (E2) metabolite, 2-methoxy estradiol (2ME2) is cytotoxic to the NF1-/- malignant tumor cell line, and inhibits proliferation in the other cell lines. 2ME2 or its derivatives could provide new treatment avenues for NF1 hormone-sensitive tumors at times of greatest hormonal influence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18213578     DOI: 10.1002/dvdy.21430

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  11 in total

1.  Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas.

Authors:  Lu Q Le; Tracey Shipman; Dennis K Burns; Luis F Parada
Journal:  Cell Stem Cell       Date:  2009-05-08       Impact factor: 24.633

Review 2.  Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis.

Authors:  Sebastian Laycock-van Spyk; Nick Thomas; David N Cooper; Meena Upadhyaya
Journal:  Hum Genomics       Date:  2011-10       Impact factor: 4.639

3.  Somatic neurofibromatosis type 1 (NF1) inactivation events in cutaneous neurofibromas of a single NF1 patient.

Authors:  Denise Emmerich; Tomasz Zemojtel; Jochen Hecht; Peter Krawitz; Malte Spielmann; Jirko Kühnisch; Karolina Kobus; Monika Osswald; Verena Heinrich; Peter Berlien; Ute Müller; Victor-F Mautner; Katharina Wimmer; Peter N Robinson; Martin Vingron; Sigrid Tinschert; Stefan Mundlos; Mateusz Kolanczyk
Journal:  Eur J Hum Genet       Date:  2014-10-08       Impact factor: 4.246

4.  Concomitant differentiation of a population of mouse embryonic stem cells into neuron-like cells and schwann cell-like cells in a slow-flow microfluidic device.

Authors:  Poornapriya Ramamurthy; Joshua B White; Joong Yull Park; Richard I Hume; Fumi Ebisu; Flor Mendez; Shuichi Takayama; Kate F Barald
Journal:  Dev Dyn       Date:  2016-11-17       Impact factor: 3.780

5.  Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cells.

Authors:  Hua Li; Xuelian Zhang; Lauren Fishbein; Frederick Kweh; Martha Campbell-Thompson; George Q Perrin; David Muir; Margaret Wallace
Journal:  Cancer Biol Ther       Date:  2010-10-15       Impact factor: 4.742

6.  Macrophage migration inhibitory factor acts as a neurotrophin in the developing inner ear.

Authors:  Lisa M Bank; Lynne M Bianchi; Fumi Ebisu; Dov Lerman-Sinkoff; Elizabeth C Smiley; Yu-chi Shen; Poornapriya Ramamurthy; Deborah L Thompson; Therese M Roth; Christine R Beck; Matthew Flynn; Ryan S Teller; Luming Feng; G Nicholas Llewellyn; Brandon Holmes; Cyrrene Sharples; Jaeda Coutinho-Budd; Stephanie A Linn; Andrew P Chervenak; David F Dolan; Jennifer Benson; Ariane Kanicki; Catherine A Martin; Richard Altschuler; Alisa E Koch; Alicia E Koch; Ethan M Jewett; John A Germiller; Kate F Barald
Journal:  Development       Date:  2012-12       Impact factor: 6.868

7.  Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol.

Authors:  Yu-chi Shen; Ravi Upadhyayula; Stephanie Cevallos; Ryan J Messick; Tammy Hsia; Mathew P Leese; Douglas M Jewett; Daysha Ferrer-Torres; Therese M Roth; Wolfgang Dohle; Barry V L Potter; Kate F Barald
Journal:  Br J Cancer       Date:  2015-10-13       Impact factor: 7.640

8.  Receptor of ghrelin is expressed in cutaneous neurofibromas of individuals with neurofibromatosis 1.

Authors:  Rafaela E Rozza-de-Menezes; Nicolle C Gaglionone; Raquel M Andrade-Losso; Orlando H K Siqueira; Lilian M Almeida; Kamila da S Peruzini; Marco A C Guimarães-Filho; Carolina I Brum; Mauro Geller; Karin S Cunha
Journal:  Orphanet J Rare Dis       Date:  2017-12-20       Impact factor: 4.123

9.  AR facilitates YAP-TEAD interaction with the AM promoter to enhance mast cell infiltration into cutaneous neurofibroma.

Authors:  Jing Jia; Haibao Zhang; Hongke Zhang; Wenbo Liu; Huicong Du; Maoguo Shu; Lin He
Journal:  Sci Rep       Date:  2019-12-18       Impact factor: 4.379

10.  Eruptive neurofibromas in pregnancy.

Authors:  Michael Xiong; Barbara A Gilchrest; Olubusayo K Obayan
Journal:  JAAD Case Rep       Date:  2014-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.